Circumvention_NN
of_IN
tolerance_NN
for_IN
the_DT
nuclear_JJ
T_NN
cell_NN
protein_NN
TCF-1_NN
by_IN
immunization_NN
of_IN
TCF-1_NN
knock-out_JJ
mice_NNS
._.

Molecular_JJ
events_NNS
that_WDT
underlie_VBP
the_DT
well-defined_JJ
phenotypic_JJ
changes_NNS
of_IN
the_DT
differentiating_VBG
thymocyte_NN
are_VBP
poorly_RB
understood_VBN
._.

A_DT
candidate_NN
gene_NN
to_TO
control_VB
thymocyte_NN
differentiation_NN
,_,
T_NN
cell_NN
factor-1_NN
-LRB-_-LRB-
TCF-1_NN
-RRB-_-RRB-
\*_NN
encodes_VBZ
a_DT
DNA-binding_JJ
protein_NN
._.

Its_PRP$
mRNA_NN
expression_NN
pattern_NN
is_VBZ
complex_JJ
during_IN
embryogenesis_NN
,_,
yet_CC
restricted_JJ
to_TO
lymphocytes_NNS
postnatally_RB
._.

Expression_NN
studies_NNS
on_IN
TCF-1_NN
protein_NN
have_VBP
been_VBN
hampered_VBN
by_IN
the_DT
difficulty_NN
to_TO
raise_VB
antibodies_NNS
due_JJ
to_TO
extreme_JJ
evolutionary_JJ
conservation_NN
._.

TCF-1_NN
knock-out_JJ
mice_NNS
,_,
generated_VBN
recently_RB
in_IN
our_PRP$
laboratory_NN
,_,
have_VBP
strongly_RB
decreased_VBN
numbers_NNS
of_IN
thymocytes_NNS
,_,
but_CC
are_VBP
otherwise_RB
normal_JJ
._.

We_PRP
have_VBP
used_VBN
these_DT
mice_NNS
to_TO
generate_VB
anti-TCF-1_NN
antibodies_NNS
._.

By_IN
immunization_NN
with_IN
a_DT
recombinant_JJ
fusion_NN
protein_NN
,_,
we_PRP
show_VBP
that_IN
TCF-1_NN
knock-out_JJ
mice_NNS
readily_RB
yield_VBP
antiserum_NN
titers_NNS
against_IN
human_JJ
and_CC
mouse_NN
TCF-1_NN
protein_NN
._.

Wild-type_JJ
littermates_NNS
remain_VBP
unresponsive_JJ
to_TO
TCF-1_NN
while_IN
they_PRP
mount_VBP
a_DT
high-titer_JJ
antibody_NN
response_NN
to_TO
the_DT
fusion_NN
protein_NN
,_,
Maltose_NN
Binding_NN
Protein_NN
-LRB-_-LRB-
MBP_NN
-RRB-_-RRB-
._.

Subsequently_RB
,_,
TCF-1-specific_JJ
hybridomas_NNS
could_MD
be_VB
prepared_VBN
from_IN
the_DT
spleens_NNS
of_IN
immunized_VBN
knock-out_JJ
mice_NNS
._.

This_DT
study_NN
illustrates_VBZ
the_DT
almost_RB
complete_JJ
tolerance_NN
of_IN
mice_NNS
for_IN
human_JJ
TCF-1_NN
and_CC
demonstrates_VBZ
that_IN
this_DT
tolerance_NN
is_VBZ
readily_RB
broken_VBN
by_IN
gene_NN
knock-out_NN
._.

Furthermore_RB
,_,
the_DT
usefulness_NN
of_IN
knock-out_JJ
mice_NNS
for_IN
the_DT
generation_NN
of_IN
monoclonal_JJ
antibodies_NNS
against_IN
the_DT
gene_NN
product_NN
of_IN
interest_NN
is_VBZ
underscored_VBN
._.

